Cargando…

Altered Th17/Treg Ratio in Peripheral Blood of Systemic Lupus Erythematosus but Not Primary Antiphospholipid Syndrome

Introduction: The role of the immune response in the pathogenesis of antiphospholipid syndrome (APS) remains elusive. It is possible that differences in the frequencies of Th17 cells and/or defects in the immunoregulatory mechanisms are involved in the pathogenesis of APS. Our aim was to determine t...

Descripción completa

Detalles Bibliográficos
Autores principales: Álvarez-Rodríguez, Lorena, Martínez-Taboada, Víctor, Calvo-Alén, Jaime, Beares, Iñaki, Villa, Ignacio, López-Hoyos, Marcos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414457/
https://www.ncbi.nlm.nih.gov/pubmed/30894863
http://dx.doi.org/10.3389/fimmu.2019.00391
_version_ 1783402979382001664
author Álvarez-Rodríguez, Lorena
Martínez-Taboada, Víctor
Calvo-Alén, Jaime
Beares, Iñaki
Villa, Ignacio
López-Hoyos, Marcos
author_facet Álvarez-Rodríguez, Lorena
Martínez-Taboada, Víctor
Calvo-Alén, Jaime
Beares, Iñaki
Villa, Ignacio
López-Hoyos, Marcos
author_sort Álvarez-Rodríguez, Lorena
collection PubMed
description Introduction: The role of the immune response in the pathogenesis of antiphospholipid syndrome (APS) remains elusive. It is possible that differences in the frequencies of Th17 cells and/or defects in the immunoregulatory mechanisms are involved in the pathogenesis of APS. Our aim was to determine the peripheral blood Th cells phenotype and the circulating cytokine profile in patients with primary APS (pAPS) and compare it with systemic lupus erythemathosus (SLE) as disease control group. Methods: The frequencies of circulating regulatory T cells (Tregs) were determined in PBMCs from 36 patients with pAPS by flow cytometry. As control groups we included 21 age- and gender-matched healthy controls (HC) and 11 patients with SLE. The suppressive capacity of Tregs was evaluated in vitro by coculture assay. On the other hand, intracellular cytokine production was assessed in Th1, Th2, and Th17 cells and circulating IL-6, IL-10, and IL-35 were measured by Cytometric Bead Array and ELISA. The quantification of Th master gene expression levels was performed by real time quantitative PCR. Results: pAPS patients and SLE patients did not show differences in the percentage or number of Tregs compared to HC. The suppressive capacity of Tregs was also similar in the three study group. Instead, we found higher FoxP3·mRNA expression levels in pAPS patients and HC than SLE patients. Regarding the Th17 response, patients with pAPS and HC showed a significantly lower frequency of circulating Th17 cells than SLE. However, no differences were observed in the Th1 response between patients and controls. Thus, increased Th17/Th1 and Th17/Treg ratios were found in SLE patients but not in pAPS patients. pAPS and SLE patients had higher serum IL-6 levels than HC but there was not difference between both disease groups. Besides, a significant increase in the immunosuppressive cytokine levels was observed only in pAPS as compared to HC. Conclusions: Our data demonstrate an increased inflammatory profile of peripheral blood CD4(+) T cells from SLE as compared with pAPS mostly due to an increased Th17 response. In conclusion, there seems not to be a direct pathogenic role for Th cells in pAPS but in SLE.
format Online
Article
Text
id pubmed-6414457
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-64144572019-03-20 Altered Th17/Treg Ratio in Peripheral Blood of Systemic Lupus Erythematosus but Not Primary Antiphospholipid Syndrome Álvarez-Rodríguez, Lorena Martínez-Taboada, Víctor Calvo-Alén, Jaime Beares, Iñaki Villa, Ignacio López-Hoyos, Marcos Front Immunol Immunology Introduction: The role of the immune response in the pathogenesis of antiphospholipid syndrome (APS) remains elusive. It is possible that differences in the frequencies of Th17 cells and/or defects in the immunoregulatory mechanisms are involved in the pathogenesis of APS. Our aim was to determine the peripheral blood Th cells phenotype and the circulating cytokine profile in patients with primary APS (pAPS) and compare it with systemic lupus erythemathosus (SLE) as disease control group. Methods: The frequencies of circulating regulatory T cells (Tregs) were determined in PBMCs from 36 patients with pAPS by flow cytometry. As control groups we included 21 age- and gender-matched healthy controls (HC) and 11 patients with SLE. The suppressive capacity of Tregs was evaluated in vitro by coculture assay. On the other hand, intracellular cytokine production was assessed in Th1, Th2, and Th17 cells and circulating IL-6, IL-10, and IL-35 were measured by Cytometric Bead Array and ELISA. The quantification of Th master gene expression levels was performed by real time quantitative PCR. Results: pAPS patients and SLE patients did not show differences in the percentage or number of Tregs compared to HC. The suppressive capacity of Tregs was also similar in the three study group. Instead, we found higher FoxP3·mRNA expression levels in pAPS patients and HC than SLE patients. Regarding the Th17 response, patients with pAPS and HC showed a significantly lower frequency of circulating Th17 cells than SLE. However, no differences were observed in the Th1 response between patients and controls. Thus, increased Th17/Th1 and Th17/Treg ratios were found in SLE patients but not in pAPS patients. pAPS and SLE patients had higher serum IL-6 levels than HC but there was not difference between both disease groups. Besides, a significant increase in the immunosuppressive cytokine levels was observed only in pAPS as compared to HC. Conclusions: Our data demonstrate an increased inflammatory profile of peripheral blood CD4(+) T cells from SLE as compared with pAPS mostly due to an increased Th17 response. In conclusion, there seems not to be a direct pathogenic role for Th cells in pAPS but in SLE. Frontiers Media S.A. 2019-03-06 /pmc/articles/PMC6414457/ /pubmed/30894863 http://dx.doi.org/10.3389/fimmu.2019.00391 Text en Copyright © 2019 Álvarez-Rodríguez, Martínez-Taboada, Calvo-Alén, Beares, Villa and López-Hoyos. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Álvarez-Rodríguez, Lorena
Martínez-Taboada, Víctor
Calvo-Alén, Jaime
Beares, Iñaki
Villa, Ignacio
López-Hoyos, Marcos
Altered Th17/Treg Ratio in Peripheral Blood of Systemic Lupus Erythematosus but Not Primary Antiphospholipid Syndrome
title Altered Th17/Treg Ratio in Peripheral Blood of Systemic Lupus Erythematosus but Not Primary Antiphospholipid Syndrome
title_full Altered Th17/Treg Ratio in Peripheral Blood of Systemic Lupus Erythematosus but Not Primary Antiphospholipid Syndrome
title_fullStr Altered Th17/Treg Ratio in Peripheral Blood of Systemic Lupus Erythematosus but Not Primary Antiphospholipid Syndrome
title_full_unstemmed Altered Th17/Treg Ratio in Peripheral Blood of Systemic Lupus Erythematosus but Not Primary Antiphospholipid Syndrome
title_short Altered Th17/Treg Ratio in Peripheral Blood of Systemic Lupus Erythematosus but Not Primary Antiphospholipid Syndrome
title_sort altered th17/treg ratio in peripheral blood of systemic lupus erythematosus but not primary antiphospholipid syndrome
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414457/
https://www.ncbi.nlm.nih.gov/pubmed/30894863
http://dx.doi.org/10.3389/fimmu.2019.00391
work_keys_str_mv AT alvarezrodriguezlorena alteredth17tregratioinperipheralbloodofsystemiclupuserythematosusbutnotprimaryantiphospholipidsyndrome
AT martineztaboadavictor alteredth17tregratioinperipheralbloodofsystemiclupuserythematosusbutnotprimaryantiphospholipidsyndrome
AT calvoalenjaime alteredth17tregratioinperipheralbloodofsystemiclupuserythematosusbutnotprimaryantiphospholipidsyndrome
AT bearesinaki alteredth17tregratioinperipheralbloodofsystemiclupuserythematosusbutnotprimaryantiphospholipidsyndrome
AT villaignacio alteredth17tregratioinperipheralbloodofsystemiclupuserythematosusbutnotprimaryantiphospholipidsyndrome
AT lopezhoyosmarcos alteredth17tregratioinperipheralbloodofsystemiclupuserythematosusbutnotprimaryantiphospholipidsyndrome